Inventor · disambiguated record
Samedy Ouk
Also filed as: OUK SAMEDY
25 granted patents·16 pending applications·337 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
41 records- 0198US7709517B2Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2006·Granted May 4, 2010·99 cites·13 claims
- 0297US8445507B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2007·Granted May 21, 2013·73 cites·31 claims
- 0396US8183274B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2010·Granted May 22, 2012·42 cites·40 claims
- 0495US9126941B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2012·Granted Sep 8, 2015·26 cites·32 claims
- 0595US8802689B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2012·Granted Aug 12, 2014·25 cites·19 claims
- 0694US9987261B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2016·Granted Jun 5, 2018·12 cites·21 claims
- 0794US8541589B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Granted Sep 24, 2013·8 cites·10 claims
- 0893US9388159B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2014·Granted Jul 12, 2016·15 cites·33 claims
- 0992US10857139B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2018·Granted Dec 8, 2020·4 cites·15 claims
- 1092US7718684B2Methods and materials for assessing prostate cancer therapies and compoundsUNIV CALIFORNIA·Filed 2005·Granted May 18, 2010·13 cites·13 claims
- 1187US8629278B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Granted Jan 14, 2014·6 cites·8 claims
- 1287US2024293383A1Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1386US2024132452A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1482US2023109968A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1581US11266648B2Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitorsIMMUNETARGET INC·Filed 2020·Granted Mar 8, 2022·1 cites·14 claims
- 1681US10266493B2Thioacetate compounds, compositions and methods of useOUK SAMEDY·Filed 2011·Granted Apr 23, 2019·2 cites·8 claims
- 1779US8207178B2Fused pyrimidines as reverse transcriptase inhibitorsSHAGINIAN ALEX·Filed 2008·Granted Jun 26, 2012·5 cites·20 claims
- 1878US2025333385A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1977US10660894B2Small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2019·Granted May 26, 2020·1 cites·1 claims
- 2075US11771687B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2020·Granted Oct 3, 2023·0 cites·28 claims
- 2175US10226464B2Small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2016·Granted Mar 12, 2019·2 cites·20 claims
- 2275US2021238145A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2372US2020079741A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 2472US2021171466A1Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2570US10919858B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2018·Granted Feb 16, 2021·0 cites·13 claims
- 2670US2019210974A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2768US9212135B2Phenylthioacetate compounds, compositions and methods of useOUK SAMEDY·Filed 2011·Granted Dec 15, 2015·1 cites·16 claims
- 2867US2015112082A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2966US2018086718A1Diarylhydantoin CompoundsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 3063US2013034501A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 3156US6794547B2Process for the synthesis of aryl alkyl monoethersPOUDRES & EXPLOSIFS STE NALE·Filed 2002·Granted Sep 21, 2004·2 cites·10 claims
- 3256US2014343111A1Diarylthiohydantoin compoundsUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3351US2022023301A1METHODS OF TREATING AUTOIMMUNE DISEASES WITH SMALL MOLECULE NF-kB INHIBITORSIMMUNETARGET INC·Filed 2021·Application pending·0 cites
- 3450US8367684B2Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2008·Granted Feb 5, 2013·0 cites·43 claims
- 3550US2008045534A1Derivatives of 1,3-diamino benzene as potassium channel modulatorsVALEANT PHARMACEUTICALS NORTH·Filed 2007·Application pending·0 cites
- 3648US8372852B2Purines as reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2012·Granted Feb 12, 2013·0 cites·20 claims
- 3744US11083729B2Methods of treating cancer with small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2018·Granted Aug 10, 2021·0 cites·17 claims
- 3843US9873674B2C-Rel inhibitors and uses thereofUNIV CORNELL·Filed 2013·Granted Jan 23, 2018·0 cites·14 claims
- 3940US2019314377A1Treatment of hematological malignancy with small molecule nf-kb inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 4039US2015322006A1Phenylthioacetate compounds, compositions and methods of useOUK SAMEDY·Filed 2015·Application pending·0 cites
- 4135US7022845B2Monomethylation of nitrogeneous heterocyclesGROUP SNPE·Filed 2003·Granted Apr 4, 2006·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Samedy Ouk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →